By Canadian Press

China gives conditional approval to Sinopharm vaccine

Dec 30, 2020 | 9:01 PM

BEIJING — China has given conditional approval to a coronavirus vaccine developed by state-owned Sinopharm.

The vaccine is the first one approved for general use in China.

Chen Shifei, the deputy commissioner of China’s Medical Production Administration, said at a news conference Thursday that the decision had been made the previous night.

The vaccine is an inactivated, two-dose vaccine from the Beijing Institute of Biological Products, a subsidiary of state-owned conglomerate Sinopharm. The company announced Wednesday that preliminary data from last-stage trials had shown it to be 79.3% effective.

Sinopharm is one of at least five Chinese developers that are in a global race to create vaccines for the disease that has killed more than 1.8 million people.

GST Holiday

Federal government's two-month GST holiday begins

14h ago

Imminent need

Council set to discuss possible location for homeless shelter on 15th Street

19h ago

International Spotlight

P.A.'s Howe one of 4 Sask. born players named to Canada's World Junior roster

Dec 13, 2024

The Associated Press